
OrganiGram Holdings OGI
$ 1.37
-3.52%
Annual report 2024
added 12-27-2025
OrganiGram Holdings Cash Conversion Cycle 2011-2026 | OGI
Annual Cash Conversion Cycle OrganiGram Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 2.92 K | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.92 K | 2.92 K | 2.92 K |
Cash Conversion Cycle of other stocks in the Drug manufacturers industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
-58.9 | - | 7.5 % | $ 6.35 M | ||
|
Catalent
CTLT
|
110 | - | - | $ 11.5 B | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | ||
|
DURECT Corporation
DRRX
|
41.4 | - | - | $ 50.1 M | ||
|
Canopy Growth Corporation
CGC
|
177 | $ 1.06 | -0.93 % | $ 114 M | ||
|
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M | ||
|
Agile Therapeutics
AGRX
|
-206 | - | 10.11 % | $ 58.2 M | ||
|
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | ||
|
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
213 | $ 2.6 | -1.14 % | $ 1.35 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
192 | - | - | $ 2.06 B | ||
|
Jupiter Wellness
JUPW
|
-21.1 | - | - | $ 33.6 M | ||
|
China Pharma Holdings
CPHI
|
164 | $ 0.55 | -3.51 % | $ 9.61 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-161 | $ 4.58 | -5.37 % | $ 64.4 M | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 3.48 | -6.2 % | $ 86.3 M | ||
|
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
18.3 | $ 38.6 | -27.96 % | $ 1.42 B | ||
|
Emergent BioSolutions
EBS
|
181 | $ 8.92 | -0.78 % | $ 457 M | ||
|
ProPhase Labs
PRPH
|
96 | - | - | $ 5.07 M | ||
|
Assertio Holdings
ASRT
|
327 | $ 11.9 | 1.06 % | $ 845 M | ||
|
Radius Health
RDUS
|
-53.5 | - | - | $ 1.42 B | ||
|
Evolus
EOLS
|
74.8 | $ 4.13 | -3.73 % | $ 266 M | ||
|
Bausch Health Companies
BHC
|
78.9 | $ 5.73 | -3.7 % | $ 2.09 B | ||
|
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | ||
|
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | ||
|
Organogenesis Holdings
ORGO
|
64.5 | $ 2.87 | -4.33 % | $ 378 M | ||
|
Perrigo Company plc
PRGO
|
137 | $ 11.39 | -7.89 % | $ 1.58 B | ||
|
Rockwell Medical
RMTI
|
45 | $ 0.9 | -0.12 % | $ 21 M | ||
|
TherapeuticsMD
TXMD
|
-723 | $ 2.22 | -0.89 % | $ 23.2 M | ||
|
Veru
VERU
|
6.7 | $ 2.52 | -3.82 % | $ 340 M | ||
|
Viatris
VTRS
|
155 | $ 14.89 | -5.16 % | $ 17.9 B | ||
|
cbdMD
YCBD
|
92 | $ 0.77 | -4.37 % | $ 3.32 M | ||
|
Pacira BioSciences
PCRX
|
209 | $ 22.1 | 3.85 % | $ 1.02 B | ||
|
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | ||
|
OptiNose
OPTN
|
314 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | ||
|
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | ||
|
SCYNEXIS
SCYX
|
106 | $ 0.75 | 0.33 % | $ 35.9 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
150 | $ 2.75 | -3.17 % | $ 3.41 M | ||
|
Tilray
TLRY
|
169 | $ 7.36 | -3.16 % | $ 4.55 B |